Marker Therapeutics Q3 EPS $(0.34) Up From $(0.80) YoY, Sales $257.61K Down From $3.95M YoY
Marker Therapeutics Q3 EPS $(0.34) Up From $(0.80) YoY, Sales $257.61K Down From $3.95M YoY
Marker Therapeutics第三季度每股收益为0.34美元，高于同比0.80美元，销售额从同比的395万美元下降25.761万美元
Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.34) per share. This is a 57.5 percent increase over losses of $(0.80) per share from the same period last year. The company reported $257.61 thousand in sales this quarter. This is a 93.48 percent decrease over sales of $3.95 million the same period last year.
Marker Therapeutics（纳斯达克股票代码：MRKR）公布季度每股亏损0.34美元。这比去年同期每股亏损0.80美元（0.80美元）增加了57.5％。该公司报告本季度销售额为257,610美元。这比去年同期的395万美元销售额下降了93.48％。